American Healthcare REIT heads into September with a striking split: analysts are upgrading targets at the fastest clip in months, while short sellers have added positions at the sharpest pace in the same period.
Short interest has become the week's defining tension for this healthcare REIT. Bears built aggressively through late August — SI jumped nearly 10% in a single week to 15.1% of the free float, and is up 27% over the past month. The absolute level, close to 26.7 million shares borrowed, is the highest reading in the 30-day history visible in the data. This is a meaningfully crowded short for a REIT of this profile, and the rebuild happened fast: from around 17.5 million shares at end of July to nearly 31 million at the August 28 peak, before a partial unwind brought it back to current levels. Days-to-cover from the most recent FINRA fortnightly report stands at 8.2 days — uncomfortably long for any short trying to exit quickly.
The lending market, however, does not support the case for a squeeze. Borrow availability has ballooned to over 1,000% — meaning there are more than ten shares available to lend for every one currently borrowed. That's the loosest it has been all year, and availability has more than doubled in just one week. Cost to borrow has also eased, now at 0.44%, down roughly 9% on the week. The ORTEX short score has pulled back from a recent peak of 66.3 on August 28 to 58.9 today, a meaningful retreat that aligns with the partial short covering seen in the SI history. The overall picture: bears added heavily then started trimming, but borrow conditions remain comfortable enough for the position to be rebuilt cheaply if sentiment turns.
The Street is firmly in the other camp. Every analyst move in the past three weeks has been a target raise — no cuts, no downgrades. Barclays lifted its target to $66 this week from $61, maintaining Overweight. Scotiabank raised to $62 from $56, keeping its Sector Outperform rating. Over the past month, Keybanc raised to $68, Citigroup to $65, and RBC and Truist both moved to $61. The consensus mean target now sits at $64, representing roughly 13% above the current price of $56.54. Bulls point to $600 million in planned 2026 acquisitions, strong Trilogy segment momentum, and projected two-year CAGR of nearly 12% for seniors housing and skilled nursing operations. Bears counter with healthcare regulatory risk, tenant credit exposure, and the complexity of the skilled nursing book. With a PE near 67 and EV/EBITDA around 20.6, valuation is not cheap, but both multiples have compressed materially — PE is down more than 11 points over the past 30 days, suggesting some re-rating has already occurred. The dividend score ranks in the 76th percentile, making this a credible income holding for REIT allocators even under the bear case.
Institutional flows add texture to the bull case. BlackRock remained the largest holder at 11.2% as of late July, with a net addition of around 565,000 shares in the most recent reported period. Vanguard entities collectively hold well above 10%, with their two main vehicles each adding positions. Cohen & Steers — a specialist REIT manager — built an entirely new position of 4.2 million shares. CenterSquare, another REIT-focused shop, added 1.4 million shares. Alyeska, a multi-strategy fund, added 2.3 million. The pattern across these specialist allocators is broadly constructive. On the activist register, no 13D filer is present — all major Schedule 13D/G positions are passive. Principal Real Estate and Wellington have both trimmed below the 5% disclosure threshold in recent filings, a small note of caution against the otherwise positive institutional flow. As always with 13D/G disclosures, these stakes reflect the last-reported position around the 5% threshold and may have shifted further since filing.
The most recent earnings print in early August produced a modest 1-day gain of roughly 1.4%, with a five-day drift slightly negative at -0.7%. The next event is not until November 6, leaving the stock to trade on macro rate dynamics and sector flow for the next two months. Peers mostly dipped on the week — WELL fell 0.3%, VTR dropped 1.9%, and NHI shed 1.5% — while AHR itself is off 0.9% over the same five sessions, broadly in line with sector weakness.
What to watch: whether the short interest rebuild of the past month continues, and whether the borrow pool — currently far looser than at any point in the prior year — tightens meaningfully as the November earnings date approaches.
See the live data behind this article on ORTEX.
Open AHR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
